Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Omega Therapeutics Inc (OMGA)

Omega Therapeutics Inc (OMGA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Why Novo Nordisk Stock Crushed the Market Today Motley Fool - Thu Jan 4, 5:08PM CST

The company just boosted its research and development efforts.

NVO : 132.41 (+3.11%)
OMGA : 2.3600 (+20.15%)
Flagship Pioneering Announces the Merger of Two Leading Programmable Medicine Platforms to Form Sail Biomedicines PR Newswire - Thu Oct 19, 2023

/PRNewswire/ -- Flagship Pioneering today announced the combination of Laronde and Senda Biosciences to launch Sail Biomedicines, a company pioneering the...

DNLI : 19.30 (+5.41%)
FHTX : 5.67 (+1.98%)
MRNA : 125.67 (+7.13%)
OMGA : 2.3600 (+20.15%)
SANA : 7.91 (+4.63%)
MCRB : 0.9651 (-5.38%)
Flagship Pioneering Appoints John Lepore as CEO-Partner and CEO of ProFound Therapeutics PR Newswire - Mon Oct 2, 2023

/PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, and ProFound™ Therapeutics, a company pioneering the discovery of a vastly expanded...

DNLI : 19.30 (+5.41%)
FHTX : 5.67 (+1.98%)
MRNA : 125.67 (+7.13%)
OMGA : 2.3600 (+20.15%)
SANA : 7.91 (+4.63%)
MCRB : 0.9651 (-5.38%)
Flagship Pioneering Named to Fortune's 2023 "Change the World" List PR Newswire - Wed Sep 27, 2023

/PRNewswire/ -- Flagship Pioneering today announced it has been named to FORTUNE's 2023 "Change the World" list, an annual global ranking of companies that...

DNLI : 19.30 (+5.41%)
FHTX : 5.67 (+1.98%)
MRNA : 125.67 (+7.13%)
OMGA : 2.3600 (+20.15%)
SANA : 7.91 (+4.63%)
MCRB : 0.9651 (-5.38%)
Flagship Pioneering Announces Appointment of Amanda Kay as Chief Business Development Officer PR Newswire - Mon Sep 11, 2023

/PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, announced today the appointment of Amanda Kay as Senior Partner and Chief Business...

DNLI : 19.30 (+5.41%)
FHTX : 5.67 (+1.98%)
MRNA : 125.67 (+7.13%)
OMGA : 2.3600 (+20.15%)
SANA : 7.91 (+4.63%)
MCRB : 0.9651 (-5.38%)
Flagship Pioneering Announces Appointment of David Khougazian as Growth Partner PR Newswire - Tue Aug 29, 2023

/PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, announced today that pharma and healthcare leader David Khougazian is joining as...

DNLI : 19.30 (+5.41%)
FHTX : 5.67 (+1.98%)
MRNA : 125.67 (+7.13%)
OMGA : 2.3600 (+20.15%)
SANA : 7.91 (+4.63%)
MCRB : 0.9651 (-5.38%)
Flagship Pioneering Appoints Jason Gardner as CEO-Partner and CEO of Ampersand Biomedicines PR Newswire - Mon Aug 14, 2023

/PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, and Ampersand Biomedicines, a company programming smarter medicines that act...

DNLI : 19.30 (+5.41%)
FHTX : 5.67 (+1.98%)
MRNA : 125.67 (+7.13%)
OMGA : 2.3600 (+20.15%)
SANA : 7.91 (+4.63%)
MCRB : 0.9651 (-5.38%)
Wall Street Analysts Think Omega Therapeutics, Inc. (OMGA) Could Surge 48.23%: Read This Before Placing a Bet Zacks - Tue May 9, 2023

The mean of analysts' price targets for Omega Therapeutics, Inc. (OMGA) points to a 48.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement...

OMGA : 2.3600 (+20.15%)
Omega Therapeutics, Inc. (OMGA) Reports Q1 Loss, Misses Revenue Estimates Zacks - Thu May 4, 2023

Omega Therapeutics, Inc. (OMGA) delivered earnings and revenue surprises of 21.88% and 31.20%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?...

OMGA : 2.3600 (+20.15%)
RVNC : 3.32 (unch)
Cellarity Strengthens Executive Leadership Team Business Wire - Tue Apr 11, 2023

Cellarity , a life sciences company founded by Flagship Pioneering to transform the way medicines are discovered, announced today the appointments of John Leaman, M.D., M.B.A., as Chief Financial Officer...

IMPL : 0.0400 (-27.27%)
SELB : 0.8812 (-8.00%)
MDGN : 5.57 (+3.15%)
DNLI : 19.30 (+5.41%)
EVLO : 0.0400 (-20.00%)
FHTX : 5.67 (+1.98%)
MRNA : 125.67 (+7.13%)
OMGA : 2.3600 (+20.15%)
SANA : 7.91 (+4.63%)
MCRB : 0.9651 (-5.38%)

Barchart Exclusives

Stock Index Futures Tread Water Ahead of Key U.S. PPI Data and Powell Remarks Barchart - 39 minutes ago
June S&P 500 E-Mini futures (ESM24) are up +0.02%, and June Nasdaq 100 E-Mini futures (NQM24) are up +0.03% this morning as investors geared up for crucial U.S. producer inflation data while also awaiting comments from Federal Reserve Chair Jerome Powell. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot